Home » Tenders » Americas » USA » Therapure TM Reagents Tender, USA - 106074828

Therapure TM Reagents Tender, USA - 106074828

HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH has floated a tender for Therapure TM Reagents. The project location is USA and the tender is closing on 30 Aug 2024. The tender notice number is NOI-NIAID-24-2229467, while the TOT Ref Number is 106074828. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Therapure TM Reagents

Deadline : 30 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 106074828

Document Ref. No. : NOI-NIAID-24-2229467

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

PRE-SOLICITATION NOTICE

Title: TheraPuretm Reagents

ID: NOI-NIAID-24-2229467

Post Date: August 20, 2024

Response Date: August 30, 2024

NAICS: 325414

Introduction

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Life Technologies, Carlsbad, California to procure TherapureTM Reagents.

The VRC/Vaccine Production Program (VPP) group is responsible for developing a scale able

GMP process the items requested need to be standardized with what will be utilized in the

VRC-s pilot plant and applicable to a GMP process and analytical standards that are used to

characterize and release therapeutic and vaccine candidates to treat diseases including Covid-

19 (SARS2-CoV), HIV, Influenza, Malaria, and Ebola. Understanding these attributes are

required for moving forward with a candidate to GMP manufacturing and clinical trials.

The VPP is interested in procuring TheraPureTM Biological Reagents

Description of need:

Manufactured by Life Technologies

TheraPureTM Pyrophosphatase, Inorganic, Pack Size-0.1, UoM-kU, Concentration-1, UoM Concentration-U/µL, # of Packs-54 TheraPureTM T7 RNA Polymerase, Pack Size-1000, UoM-kU, Concentration-200, UoM Concentration- U/µL, # of Packs-27 TheraPureTM RNase Inhibitor, Pack Size-50, UoM-kU, Concentration-40, UoM Concentration-U/µL, # of Packs-9 TheraPureTM ATP 100 mM Sodium Solution, Pack Size-5, UoM-ML, Concentration-100, UoM Concentration-mM, # of Packs-54 TheraPureTM CTP 100 mM Sodium Solution, Pack Size-5, UoM-ML, Concentration-100, UoM Concentration-mM, # of Packs-54 TheraPureTM GTP 100mM Sodium Solution, Pack Size-5, UoM-ML, Concentration-100, UoM Concentration-mM, # of Packs-54 Shipping and Handling FOB Destination, QTY 1The statutory authority for this sole so...
Active Contract Opportunity
Notice ID : NOI-NIAID-24-2229467
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 20, 2024 11:26 pm EDT
Original Response Date: Aug 30, 2024 04:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Sep 14, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Gaithersburg, MD 20878 USA